Story thread · 10 reports / 7 sources
Definium rises as LSD pill achieves primary goal in late-stage trial for anxiety
seekingalpha.com · 19h
How the coverage leans
Across 7 sources · syndicated copies counted once
First report: Definium Therapeutics to Discuss Topline Results from Phase 3 Panorama Study in Generalized Anxiety Disorder on September 14, 2026 — financialpost.com, 1d
The coverage
- Definium, Up 190% This Year, Succeeds Again With Synthetic LSD; Shares Fly
finance.yahoo.com · 21h
- LSD-based Drug Lowers Anxiety in Second Successful Late-stage Study
medscape.com · 1d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.